About the Company
Stereotaxis Inc. is an American publicly traded corporation based in St. Louis MO, that makes robotic products to improve the clinical outcomes of electrophysiology studies. The most notable of Stereotaxis’ products is the NIOBE® ES Remote Magnetic Navigation (RMN) System. With the first iterations of the RMN system originally designed for applications within the brain, its current usage is guiding magnetic catheters during electrophysiology studies and catheter ablation procedures to treat arrhythmias in the heart. The technology has been approved by regulatory agencies in the United States, European Union and other countries around the world. Systems operate within cardiac catheter labs in hospitals and have been utilized in over 100,000 procedures worldwide as of 2017. In January 2022, Stereotaxis announced that the Fuwai Central China Cardiovascular Hospital has become the first in central China to establish a robotic electrophysiology program with the company's robotic magnetic navigation technology.
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic Apparatus
Employees
182
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $STXS News
Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary ...
Stereotaxis, Abbott Ink Pact To Combine Mapping & Robotic Tech: FDA Approves Abbott's Next-Gen Abalation Catheter
Stereotaxis Inc (NYSE: STXS) shares are gaining after the company announced a global collaboration with Abbott Laboratories (NYSE: ABT) to integrate Abbott's EnSite X EP System with Stereotaxis ...
Stereotaxis Inc (STXS) Stock: A Look at the Analyst Recommendations
To put it simply, Stereotaxis Inc (STXS) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important ...
Stereotaxis (NYSEMKT: STXS)
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary ...
Stereotaxis up, Boeing down in index of St. Louis-area publicly traded stocks
The top five performers year to date, with Brown’s analysis, are: Stereotaxis Inc. (NYSE: STXS) – up 49.14%. The company manufactures and designs systems to treat abnormal heart rhythms and ...
Stereotaxis, Inc. (STXS) Interactive Stock Chart - Yahoo Finance
Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript March 4, 2024 Stereotaxis, Inc. reports earnings inline with expectations. Reported EPS is $-0.07 EPS, expectations were $-0.07. STXS isn ...
Stereotaxis Inc RJR1
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Stereotaxis, Inc. (STXS)
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that ...
Stereotaxis Inc. (RJR1.SG)
Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript March 4, 2024 Stereotaxis, Inc. reports earnings inline with expectations. Reported EPS is $-0.07 EPS, expectations were $-0.07.
Stereotaxis Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...